Pressebereich

Actions

160517 PR VI EuroPCR BIOSOLVE trial EN

Actions

EuroPCR 2016: Magmaris*, the First Clinically Proven Bioresorbable Magnesium Scaffold, Shows Long-Term Safety in BIOSOLVE-II Trial

12 Month Results Demonstrate No Incidence of Scaffold Thrombosis and Low Rate of Target Lesion Failure






Please contact us if you require further information

${loading}